missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ A1BG Monoclonal Antibody (C1), Invitrogen™
Description
Alpha-1-B glycoprotein (A1BG) which is a plasma protein with no known function belongs to the immunoglobulin superfamily. Although the human A1BG has been known for four decades, and the information about the amino acid sequence, chromosomal assignment, and even genetic polymorphism in different populations have been known, no biological function has been suggested. A1BG (Mr approximately equal to 63,000) consists of one polypeptide chain of 474 amino acids with four glucosamine oligosaccharides. The polypeptide has five intrachain disulfide bonds and consists of five repeating structural domains, each containing about 95 amino acids and one disulfide bond. Recently human cysteine-rich secretory protein 3 (CRISP-3) has been found to be a binding partner of A1B, suggesting the A1BG-CRISP-3 complex displays a protecting function from a potentially harmful effect of free CRISP-3 in circulation.
Spécification
Spécification
| Antigène | A1BG |
| Applications | Western Blot, Immunocytochemistry |
| Classification | Monoclonal |
| Clone | C1 |
| Concentration | 1 mg/mL |
| Conjugué | Unconjugated |
| Formule | PBS with 50% glycerol and 0.05% ProClin 300; pH 7.4 |
| Expression | A1BG |
| Numéro d’ordre du gène | P04217 |
| Alias de gène | A1B; A1bg; A1bg {ECO:0000312; ABG; Alpha-1-B glycoprotein; alpha-1-B-glycoprotein; alpha-1B-glycoprotein; alpha1B-glycoprotein; C44; DKFZp686F0970; epididymis secretory sperm binding protein Li 163pA; GAB; HEL-S-163pA; HYST2477; Liver regeneration-related protein 1; RGD:69417} |
| Afficher plus |
Nom du produit
En cliquant sur Soumettre, vous reconnaissez que vous pouvez être contacté par Fisher Scientific au sujet des informations que vous avez fournies dans ce formulaire. Nous ne partagerons pas vos informations à d'autres fins. Toutes les informations de contact fournies seront également conservées conformément à notre politique de confidentialité. Politique de confidentialité.
Vous avez repéré une opportunité d'amélioration ?